Filing Details

Accession Number:
0001415889-24-002412
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-02 21:28:21
Reporting Period:
2024-01-31
Accepted Time:
2024-02-02 21:28:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1759425 Mirum Pharmaceuticals Inc. MIRM Pharmaceutical Preparations (2834) 831281555
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1974200 Jolanda Howe C/O Mirum Pharmaceuticals, Inc.
950 Tower Lane, Suite 1050
Foster City CA 94404
Svp, Global Controller No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-01-31 1,772 $0.00 2,494 No 4 M Direct
Common Stock Disposition 2024-02-02 735 $26.19 1,759 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2024-01-31 1,772 $0.00 1,772 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,543 No 4 M Direct
Footnotes
  1. Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer).
  2. Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.
  3. The restricted stock units vest in a series of three successive equal annual installments beginning January 31, 2024. 1,772 shares vested on January 31, 2024 ; 1,772 shares will vest January 31, 2025 and the remaining 1,771 shares will vest on January 31, 2026.